Rareş Drulă

1.3k total citations · 1 hit paper
18 papers, 914 citations indexed

About

Rareş Drulă is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Rareş Drulă has authored 18 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Hematology. Recurrent topics in Rareş Drulă's work include MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (5 papers). Rareş Drulă is often cited by papers focused on MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (5 papers). Rareş Drulă collaborates with scholars based in Romania, United States and Czechia. Rareş Drulă's co-authors include Cornelia Braicu, Alexandru Irimie, Călin Ionescu, Diana Gulei, Alexandru Rusu, Atanas G. Atanasov, Mihail Buse, Lajos Ráduly, Constantin Busuioc and Ioana Berindan‐Neagoe and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Rareş Drulă

17 papers receiving 907 citations

Hit Papers

A Comprehensive Review on MAPK: A Promising Therapeutic T... 2019 2026 2021 2023 2019 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rareş Drulă Romania 11 601 292 189 115 84 18 914
Mihail Buse Romania 8 511 0.9× 176 0.6× 180 1.0× 99 0.9× 83 1.0× 14 878
Kui Sheng Chen China 2 606 1.0× 241 0.8× 216 1.1× 144 1.3× 99 1.2× 5 1.0k
Xi Yu China 15 410 0.7× 227 0.8× 162 0.9× 101 0.9× 60 0.7× 43 747
Haolan Wang China 6 520 0.9× 192 0.7× 251 1.3× 124 1.1× 61 0.7× 9 861
Wuxuan Mei China 9 425 0.7× 220 0.8× 193 1.0× 135 1.2× 96 1.1× 16 735
Lin Cao China 19 732 1.2× 342 1.2× 212 1.1× 83 0.7× 75 0.9× 49 1.1k
Jing Tian China 18 751 1.2× 498 1.7× 175 0.9× 115 1.0× 75 0.9× 51 1.1k
Yi-Chieh Yang Taiwan 15 650 1.1× 325 1.1× 165 0.9× 108 0.9× 37 0.4× 19 869
Nengming Lin China 19 569 0.9× 173 0.6× 221 1.2× 180 1.6× 72 0.9× 55 870
Ursula Cesta Incani Italy 7 489 0.8× 188 0.6× 187 1.0× 106 0.9× 73 0.9× 9 703

Countries citing papers authored by Rareş Drulă

Since Specialization
Citations

This map shows the geographic impact of Rareş Drulă's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rareş Drulă with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rareş Drulă more than expected).

Fields of papers citing papers by Rareş Drulă

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rareş Drulă. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rareş Drulă. The network helps show where Rareş Drulă may publish in the future.

Co-authorship network of co-authors of Rareş Drulă

This figure shows the co-authorship network connecting the top 25 collaborators of Rareş Drulă. A scholar is included among the top collaborators of Rareş Drulă based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rareş Drulă. Rareş Drulă is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Drulă, Rareş & George A. Călin. (2024). MicroRNAs: where brilliance, perseverance, and ambition converged. Journal of Clinical Investigation. 135(2). 2 indexed citations
2.
Țigu, Adrian Bogdan, Raluca Munteanu, Cristian Moldovan, et al.. (2024). Therapeutic advances in the targeting of ROR1 in hematological cancers. Cell Death Discovery. 10(1). 471–471. 3 indexed citations
3.
Munteanu, Raluca, Cristian Moldovan, Adrian Bogdan Țigu, et al.. (2024). 5-Azacytidine treatment inhibits the development of lung cancer models via epigenetic reprogramming and activation of cellular pathways with anti-tumor activity. Medicine and Pharmacy Reports. 97(4). 488–506. 1 indexed citations
4.
Popescu, Codruța Alina, Carina Mihu, Diana Cenariu, et al.. (2024). Is Mir-205 a possible biomarker for evaluating treatment response in psoriasis?. Journal of Medicine and Life. 17(3). 353–359. 2 indexed citations
5.
Țigu, Adrian Bogdan, Diana Cenariu, Sergiu Paşca, et al.. (2024). Single low‐dose decitabine as frontline therapy of acute myeloid leukaemia, with venetoclax salvage. Journal of Cellular and Molecular Medicine. 28(20). e18592–e18592.
6.
Drulă, Rareş, Cornelia Braicu, & Ioana Berindan‐Neagoe. (2024). Current advances in circular RNA detection and investigation methods: Are we running in circles?. Wiley Interdisciplinary Reviews - RNA. 15(3). e1850–e1850. 14 indexed citations
7.
Drulă, Rareş, Cornelia Braicu, Sergiu Chira, & Ioana Berindan‐Neagoe. (2023). Investigating Circular RNAs Using qRT-PCR; Roundup of Optimization and Processing Steps. International Journal of Molecular Sciences. 24(6). 5721–5721. 12 indexed citations
8.
Țigu, Adrian Bogdan, Rareş Drulă, Alina‐Andreea Zimța, et al.. (2023). RNA sequencing suggests that non‐coding RNAs play a role in the development of acquired haemophilia. Journal of Cellular and Molecular Medicine. 27(13). 1790–1796. 2 indexed citations
9.
Gulei, Diana, Rareş Drulă, Gabriel Ghiaur, et al.. (2023). The Tumor Suppressor Functions of Ubiquitin Ligase KPC1: From Cell-Cycle Control to NF-κB Regulator. Cancer Research. 83(11). 1762–1767. 10 indexed citations
10.
Gulei, Diana, Rareş Drulă, Diana Cenariu, et al.. (2023). Proteasome inhibition in combination with immunotherapies: State-of-the-Art in multiple myeloma. Blood Reviews. 61. 101100–101100. 11 indexed citations
11.
Drulă, Rareş, Diana Gulei, Cristina Adela Iuga, et al.. (2022). Exploiting the ubiquitin system in myeloid malignancies. From basic research to drug discovery in MDS and AML. Blood Reviews. 56. 100971–100971. 10 indexed citations
12.
Drulă, Rareş, Radu Pîrlog, Monica Trif, et al.. (2021). circFOXO3: Going around the mechanistic networks in cancer by interfering with miRNAs regulatory networks. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1867(5). 166045–166045. 9 indexed citations
13.
Pîrlog, Radu, Rareş Drulă, Andreea Nuţu, George A. Călin, & Ioana Berindan‐Neagoe. (2021). The Roles of the Colon Cancer Associated Transcript 2 (CCAT2) Long Non-Coding RNA in Cancer: A Comprehensive Characterization of the Tumorigenic and Molecular Functions. International Journal of Molecular Sciences. 22(22). 12491–12491. 27 indexed citations
14.
Drulă, Rareş, Cornelia Braicu, Antonia Haranguș, et al.. (2020). Critical function of circular RNAs in lung cancer. Wiley Interdisciplinary Reviews - RNA. 11(5). 35 indexed citations
15.
Barth, Dominik A., Rareş Drulă, Leonie Ott, et al.. (2020). Circulating Non-coding RNAs in Renal Cell Carcinoma—Pathogenesis and Potential Implications as Clinical Biomarkers. Frontiers in Cell and Developmental Biology. 8. 828–828. 26 indexed citations
16.
Drulă, Rareş, Leonie Ott, Ioana Berindan‐Neagoe, Klaus Pantel, & George A. Călin. (2020). MicroRNAs from Liquid Biopsy Derived Extracellular Vesicles: Recent Advances in Detection and Characterization Methods. Cancers. 12(8). 2009–2009. 47 indexed citations
17.
Barth, Dominik A., Ondřej Slabý, Christiane Klec, et al.. (2019). Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma. Cancers. 11(10). 1580–1580. 32 indexed citations
18.
Braicu, Cornelia, Mihail Buse, Constantin Busuioc, et al.. (2019). A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer. Cancers. 11(10). 1618–1618. 671 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026